VivoSeq
Other

Controlled Ovarian Stimulation

0

Pipeline Programs↗

4

Active Trials↗

2

Companies Involved↗

Controlled Ovarian Stimulation is an early-stage landscape with 0 programs across 2 companies. The most active players are Ferring, Merck & Co..

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

71/100

Attrition Rate

18/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Ferring logo

Ferring

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

28

clinical trials

Completed15 · 54%
Terminated4 · 14%
Recruiting4 · 14%
Unknown status3 · 11%
Suspended1 · 4%
Withdrawn1 · 4%

Clinical Trials

Trial Activity

28 trials

Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation
Recruiting·UUniversity of Southern California·Phase 4·NCT06701071·120 enrolled
Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders
Recruiting·UUniversity Hospital, Ghent·Phase 4·NCT04487925·208 enrolled
Effects of Letrozole During the Luteal Phase After Controlled Ovarian Stimulation in Oocyte Donors.
Recruiting·IIVI Madrid·Phase 3·NCT06244745·152 enrolled
Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET).
Recruiting·LLG Chem·Phase 4·NCT06921395·248 enrolled
Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women
Completed·Ferring logoFerring·Phase 3·NCT03228680·373 enrolled
A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.
Completed·Ferring logoFerring·Phase 2·NCT03564509·620 enrolled
A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703)
Completed·—·Phase 3·NCT00725491·259 enrolled
Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women
Completed·Ferring logoFerring·Phase 3·NCT03296527·1,011 enrolled
Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)
Completed·—·Phase 3·NCT00696878·682 enrolled
Supplementation With Human Chorionic Gonadotropin (hCG) During Controlled Ovarian Stimulation With Recombinant Follicle-stimulating Hormone (FSH) for In Vitro Fertilisation
Completed·—·Phase 4·NCT00844311·60 enrolled
A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation
Completed·Ferring logoFerring·Phase 3·NCT02449889·176 enrolled
Individual Versus Standard Follicle Stimulating Hormone Dose for Controlled Ovarian Stimulation and Insemination
Completed·NNina la Cour Freiesleben·Phase 4·NCT00374634·234 enrolled
Step Up Versus Step Down in Controlled Ovarian Stimulation
Completed·PParc de Salut Mar·Phase 4·NCT01376999·158 enrolled
Follicular Steroid Genesis in Controlled Ovarian Stimulation
Completed·IInstituto Valenciano de Infertilidad, IVI VALENCIA·Phase 4·NCT02738580·112 enrolled
Influence of FSH/LH Ratio in Controlled Ovarian Stimulation
Completed·HHospital de Cruces·Phase 1·NCT02994550·447 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)